Aspire Biopharma
Quarterly Financials
| Values in thousands | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | 0 | 0 | ||
EBITDA | -15,651 | -11,075 | -243 | -96 |
Net Income | -15,941 | -11,966 | -244 | -96 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -1,751 | 479 | -495 | -56 |
Cash | 1,346 | 3 | 16 | 19 |
Basic Shares | 46,007 | 46,007 | 46,007 | 46,007 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | 0 | 0 | |
EBITDA | -11,646 | 4,473 | -596 |
Net Income | -12,537 | 4,464 | -597 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -265 | 11 | -5,038 |
Cash | 3 | 11 | |
Basic Shares | 46,007 | 46,007 | 46,007 |
